/
Healthcare Realty Trust Incorporated is a self-managed and self-administered real estate investment trust ( REIT ) that owns, leases, manages, acquires, finances, develops and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States. All references in this report to "Healthcare Realty," the "Company,…
$21.32
+$0.03 (+0.14%)
EOD Jul 17, 2026
Revenue declined 6.9% YoY. The question is whether this is cyclical or a structural shift.
Insufficient data to identify specific risks. Treat any missing metrics as a data gap, not a clean bill of health.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$1.16B
▼ -6.9% YoY
Net Income (TTM)
-$201M
▲ +62.4% YoY
Op. Margin
—
ROIC
—
Cash Flow & Balance Sheet
FCF
N/A
Op. Cash Flow (TTM)
$462M
▼ -8.9% YoY
Net Debt
$4.31B
Cash & Equiv.
$26M
5Y CAGR: +18.8%
5Y CAGR: -3.4%
Continue Research
Healthcare Realty Trust (HR) trades above a two-stage DCF intrinsic value of about $-5.66 per share, so at $21.32 the stock looks overvalued (126.5% above estimated intrinsic value). A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Healthcare Realty Trust scores 11/100 on Intrinsiqq's quality scorecard (a lower-quality business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. It currently yields about 4.9%; see dividend safety for coverage and history. All figures are computed from SEC filings; read the full methodology. This is analysis, not investment advice.
Intrinsiqq's two-stage DCF estimates an intrinsic value of about $-5.66 per share for HR, projecting its recent free cash flow forward with a growth rate that fades toward a long-run rate and discounting it back to today. Applying a 25% margin of safety gives a more conservative fair-value entry around $-4.24. At today's $21.32, that puts the stock about 126.5% above estimated intrinsic value. The result is sensitive to the growth and discount-rate inputs, so it is best to run conservative, base and optimistic cases. You can adjust all of them yourself with the sliders on the DCF tab.
Healthcare Realty Trust scores 11 out of 100 on Intrinsiqq's quality score, a weighted blend of 4 metrics each scored 0 to 100, which makes it a lower-quality business on these measures. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
Yes, Healthcare Realty Trust pays a regular dividend of about $1.04 per share per year (typically in quarterly installments), a yield of roughly 4.9% at the current price. Healthcare Realty Trust has grown the dividend at roughly 21.9% a year over the past few years. A low headline yield is not the same as a weak dividend: what matters is how well earnings and free cash flow cover the payout and whether it is growing, not the percentage alone. For HR's full payout history, growth streak and dividend-safety score, see the dividends tab.
That depends on valuation and quality together, not either alone. HR currently trades above its estimated intrinsic value and scores 11/100 on quality (lower-quality). It also yields about 4.9%. A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.